Neuro-fuzzy system for prostate cancer diagnosis

Urology

Volumn 68, Issue 2, 2006, Pages 357-361

  Benecchi, Luigi ^a  

^a Fidenza Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; ARTIFICIAL NEURAL NETWORK; CANCER DIAGNOSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NEURO FUZZY SYSTEM; OUTPATIENT; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; ROC CURVE;

AGED; AGED, 80 AND OVER; FUZZY LOGIC; HUMANS; MALE; MIDDLE AGED; NEURAL NETWORKS (COMPUTER); PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 33746862009     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.03.003     Document Type: Article

References (29)

1. Catalona W.J., Smith D.S., Ratliff T.L., et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324 (1991) 1156-1161
2. Woolf S.H. Screening for prostate cancer with prostate-specific antigen. an examination of evidence. N Engl J Med 1333 (1995) 1401-1405
3. Catalona W.J., Smith D.S., Wolfert R.L., et al. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 274 (1995) 1214-1220
4. Marley G.M., Miller M.C., Kattan M.W., et al. Free and complexed prostate-specific antigen serum ratios to predict probability of primary prostate cancer and benign prostatic hyperplasia. Urology 48 (1996) 16-22
5. Optenberg S.A., Clark J.Y., Brawer M.K., et al. Development of a decision-making tool to predict risk of prostate cancer. the Cancer of the Prostate Risk Index (CAPRI) test. Urology 50 (1997) 665-672
6. Carlson G.D., Calvanese C.B., and Partin A.W. An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer. results on 4298 cases. Urology 52 (1998) 455-461
7. Kranse R., Beemsterboer P., Rietbergen J., et al. Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region). Prostate 39 (1999) 316-322
8. Wei J.T., Zhang Z., Barnhill S.D., et al. Understanding artificial neural networks and exploring their potential applications for the practicing urologist. Urology 52 (1998) 161-172
9. Snow P.B., Smith D.S., and Catalona W.J. Artificial neural networks in the diagnosis and prognosis of prostate cancer. a pilot study. J Urol 152 (1994) 1923-1926
10. Dubois D., and Prade H. An introduction to fuzzy systems. Clin Chim Acta 270 (1998) 3-29
11. Kuncheva L.I., and Steimann F. Fuzzy diagnosis. Artif Intell Med 16 (1999) 121-128
12. Nauck D., and Kruse R. Obtaining interpretable fuzzy classification rules from medical data. Artif Intell Med 16 (1999) 149-169
13. Jang J.-S.R. ANFIS. Adaptive-network-based fuzzy inference system. IEEE Trans Syst Man Cybern 233 (1993) 665-685
14. Sproule B.A., Naranjo C.A., and Turksen I.B. Fuzzy pharmacology. theory and applications. Trend Pharmacol Sci 23 (2002) 412-417
15. Dazzi D., Taddei F., Gavarini A., et al. The control of blood glucose in the critical diabetic patient. a neuro-fuzzy method. J Diabetes Complications 15 (2001) 80-87
16. Wen Y., and Xiaoou L. Fuzzy identification using fuzzy neural networks with stable learning algorithms. IEEE Trans Fuzzy Syst 12 (2004) 411-420
17. Belal S.Y., Taktak A.F.G., Nevill A.J., et al. Automatic detection of distorted plethysmogram pulses in neonates and pediatric patients using an adaptive-network-based fuzzy inference system. Artif Intell Med 24 (2002) 149-165
18. Virant-Klun I., and Virant J. Fuzzy logic alternative for analysis in the biomedical sciences. Comput Biomed Res 32 (1999) 305-321
19. Catalona W.L., Smith D.S., Ratliff T.L., et al. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 270 (1993) 948-954
20. Catalona W.J., Richie P., Ahmann F.R., et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer. results of a multicenter clinical trial of 6,630 men. J Urol 151 (1994) 1283-1290
21. Reissigl A., Klocker H., Pointner J., et al. Usefulness of the ratio free/total prostate-specific antigen in addition to total PSA levels in prostate cancer screening. Urology 48 (1996) 62-66
22. Horninger W., Reissigl A., Mocker H., et al. Improvement of specificity in PSA based screening by using PSA-transition zone density and percent free PSA in addition to total PSA levels. Prostate 37 (1998) 133-139
23. Horninger W., Bartsch G., Snow P.B., et al. The problem of cutoff levels in a screened population. Cancer 91 suppl 8 (2001) 1667-1671
24. Virtanen A., Gomari M., Kranse R., et al. Estimation of prostate cancer probability by logistic regression. free and total prostate-specific antigen, digital rectal examination, and heredity are significant. Clin Chem 45 (1999) 987-994
25. Kalra P., Togami J., Bansal B.S.G., et al. A neurocomputational model for prostate carcinoma detection. Cancer 98 (2003) 1849-1854
26. Sargent D.J. Comparison of artificial neural networks with other statistical approaches. Cancer 91 (2001) 1636-1642
27. Finne P., Finne R., Auvinen A., et al. Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network. Urology 56 (2000) 418-422
28. Djavan B., Remzi M., Zlotta A., et al. Novel artificial neural network for early detection of prostate cancer. J Clin Oncol 20 (2002) 921-929
29. Carsten S., Cammann H., Semjonow A., et al. Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsies. Clin Chem 48 (2002) 1279-1287